What we did earlier? 

1. Stability indicating assay methods of pharmaceuticals and their combined dosages by HPLC and HPTLC.
2. Bioanalytical method development and validation of drugs and its metabolites by HPLC for its pharmacokinetic evaluation.
3. Dissolution development of drugs in its combined dosage forms.
4. Drug-drug interaction studies.
5. Stability studies of active pharmaceutical ingredients and dosage forms as per ICH guidelines.
6. Analytical method development of drugs present in combined dosage forms.
7. Forced degradation studies (Stress conditions) and accelerated stability conditions of API and combined dosage forms.

Earlier Research Work

1. Estimation of Azithromycin in Gingival fluid
2. Estimation of Ascorbic acid in biomatrix
3. Estimation of Clobesatol in rat plasma 

 Current Research Work:

1. Formulation development and pharmacokinetic study
2. Analytical and bioanalytical method development
3. Validation by HPLC, GC-MS, HPTLC, per US FDA, ICH guidelines. Stability study and protocol development for Unani medicines